Expanded Table: Some Vaccines for Adults (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

October 17, 2022

View Complete Issue Table of Contents 2019

Download PDF: US English

Disclosures & Objectives Disclosures & Objectives

Show Related Terms Hide Related Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2022 Oct 17;64(1661):e170-3

Disclosures

Principal Faculty

Mark Abramowicz, M.D., President has disclosed no relevant financial relationships.
Jean-Marie Pflomm, Pharm.D., Editor in Chief has disclosed no relevant financial relationships.
Brinda M. Shah, Pharm.D., Consulting Editor has disclosed no relevant financial relationships.

Additional Contributor(s)

Amy Faucard, MLS, Associate Editor has disclosed no relevant financial relationships.

Objective(s)

Upon completion of this activity, the participant will be able to:

Discuss the current recommendations for vaccination of adults in the US.
Review available vaccine preparations and their recommended dosages, schedules, possible adverse effects, and contraindications for use.
Determine the most appropriate vaccines for a given patient.

Select a term to see related articles ActHIB Adacel Bexsero Boostrix diphtheria DTaP Engerix-B Gardasil9 Haemophilus influenzae Havrix hepatitis a hepatitis b Heplisav-B Hiberix measles meningococcal vaccine MenQuadfi Menveo MMR MMR II PedvaxHIB pertussis Pneumovax 23 PPSV23 PreHevbrio Prevnar Priorix Recombivax HB Shingles Shingrix Tdap Tdvax Tenivac tetanus Trumenba Twinrix vaccines Vaqta Varivax Vaxneuvance

View the Expanded Table: Some Vaccines for Adults
Download PDF: US English | Canadian-English

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.